PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
XPEL vs. MOH
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between XPEL and MOH is 0.08, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.1

Performance

XPEL vs. MOH - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in XPEL, Inc. (XPEL) and Molina Healthcare, Inc. (MOH). The values are adjusted to include any dividend payments, if applicable.

1,200.00%1,400.00%1,600.00%1,800.00%2,000.00%2,200.00%AugustSeptemberOctoberNovemberDecember2025
2,024.50%
1,326.55%
XPEL
MOH

Key characteristics

Sharpe Ratio

XPEL:

-0.28

MOH:

-0.45

Sortino Ratio

XPEL:

0.09

MOH:

-0.46

Omega Ratio

XPEL:

1.02

MOH:

0.94

Calmar Ratio

XPEL:

-0.30

MOH:

-0.50

Martin Ratio

XPEL:

-0.72

MOH:

-0.81

Ulcer Index

XPEL:

28.09%

MOH:

21.47%

Daily Std Dev

XPEL:

73.91%

MOH:

38.85%

Max Drawdown

XPEL:

-99.77%

MOH:

-68.37%

Current Drawdown

XPEL:

-58.10%

MOH:

-27.46%

Fundamentals

Market Cap

XPEL:

$1.17B

MOH:

$17.41B

EPS

XPEL:

$1.75

MOH:

$19.66

PE Ratio

XPEL:

24.28

MOH:

15.48

Total Revenue (TTM)

XPEL:

$312.87M

MOH:

$30.13B

Gross Profit (TTM)

XPEL:

$133.66M

MOH:

$3.60B

EBITDA (TTM)

XPEL:

$55.48M

MOH:

$1.47B

Returns By Period

In the year-to-date period, XPEL achieves a 6.38% return, which is significantly higher than MOH's 4.56% return. Over the past 10 years, XPEL has outperformed MOH with an annualized return of 34.61%, while MOH has yielded a comparatively lower 19.40% annualized return.


XPEL

YTD

6.38%

1M

5.70%

6M

7.22%

1Y

-22.62%

5Y*

21.88%

10Y*

34.61%

MOH

YTD

4.56%

1M

3.45%

6M

-9.25%

1Y

-13.94%

5Y*

18.89%

10Y*

19.40%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

XPEL vs. MOH — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

XPEL
The Risk-Adjusted Performance Rank of XPEL is 3232
Overall Rank
The Sharpe Ratio Rank of XPEL is 3131
Sharpe Ratio Rank
The Sortino Ratio Rank of XPEL is 3434
Sortino Ratio Rank
The Omega Ratio Rank of XPEL is 3535
Omega Ratio Rank
The Calmar Ratio Rank of XPEL is 2828
Calmar Ratio Rank
The Martin Ratio Rank of XPEL is 3030
Martin Ratio Rank

MOH
The Risk-Adjusted Performance Rank of MOH is 2222
Overall Rank
The Sharpe Ratio Rank of MOH is 2323
Sharpe Ratio Rank
The Sortino Ratio Rank of MOH is 2020
Sortino Ratio Rank
The Omega Ratio Rank of MOH is 2121
Omega Ratio Rank
The Calmar Ratio Rank of MOH is 1616
Calmar Ratio Rank
The Martin Ratio Rank of MOH is 2828
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

XPEL vs. MOH - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for XPEL, Inc. (XPEL) and Molina Healthcare, Inc. (MOH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for XPEL, currently valued at -0.28, compared to the broader market-2.000.002.004.00-0.28-0.45
The chart of Sortino ratio for XPEL, currently valued at 0.09, compared to the broader market-4.00-2.000.002.004.006.000.09-0.46
The chart of Omega ratio for XPEL, currently valued at 1.02, compared to the broader market0.501.001.502.001.020.94
The chart of Calmar ratio for XPEL, currently valued at -0.30, compared to the broader market0.002.004.006.00-0.30-0.50
The chart of Martin ratio for XPEL, currently valued at -0.72, compared to the broader market0.0010.0020.0030.00-0.72-0.81
XPEL
MOH

The current XPEL Sharpe Ratio is -0.28, which is higher than the MOH Sharpe Ratio of -0.45. The chart below compares the historical Sharpe Ratios of XPEL and MOH, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.00-0.500.000.50AugustSeptemberOctoberNovemberDecember2025
-0.28
-0.45
XPEL
MOH

Dividends

XPEL vs. MOH - Dividend Comparison

Neither XPEL nor MOH has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

XPEL vs. MOH - Drawdown Comparison

The maximum XPEL drawdown since its inception was -99.77%, which is greater than MOH's maximum drawdown of -68.37%. Use the drawdown chart below to compare losses from any high point for XPEL and MOH. For additional features, visit the drawdowns tool.


-70.00%-60.00%-50.00%-40.00%-30.00%-20.00%-10.00%AugustSeptemberOctoberNovemberDecember2025
-58.10%
-27.46%
XPEL
MOH

Volatility

XPEL vs. MOH - Volatility Comparison

XPEL, Inc. (XPEL) has a higher volatility of 9.88% compared to Molina Healthcare, Inc. (MOH) at 8.52%. This indicates that XPEL's price experiences larger fluctuations and is considered to be riskier than MOH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%10.00%20.00%30.00%40.00%AugustSeptemberOctoberNovemberDecember2025
9.88%
8.52%
XPEL
MOH

Financials

XPEL vs. MOH - Financials Comparison

This section allows you to compare key financial metrics between XPEL, Inc. and Molina Healthcare, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab